BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23518714)

  • 21. Expression of ataxin-7 in CNS and non-CNS tissue of normal and SCA7 individuals.
    Jonasson J; Ström AL; Hart P; Brännström T; Forsgren L; Holmberg M
    Acta Neuropathol; 2002 Jul; 104(1):29-37. PubMed ID: 12070661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins.
    Janer A; Martin E; Muriel MP; Latouche M; Fujigasaki H; Ruberg M; Brice A; Trottier Y; Sittler A
    J Cell Biol; 2006 Jul; 174(1):65-76. PubMed ID: 16818720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization.
    Chen S; Peng GH; Wang X; Smith AC; Grote SK; Sopher BL; La Spada AR
    Hum Mol Genet; 2004 Jan; 13(1):53-67. PubMed ID: 14613968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
    Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
    J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions.
    Lebre AS; Jamot L; Takahashi J; Spassky N; Leprince C; Ravisé N; Zander C; Fujigasaki H; Kussel-Andermann P; Duyckaerts C; Camonis JH; Brice A
    Hum Mol Genet; 2001 May; 10(11):1201-13. PubMed ID: 11371513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyglutamine-expanded ataxin-7 activates mitochondrial apoptotic pathway of cerebellar neurons by upregulating Bax and downregulating Bcl-x(L).
    Wang HL; Yeh TH; Chou AH; Kuo YL; Luo LJ; He CY; Huang PC; Li AH
    Cell Signal; 2006 Apr; 18(4):541-52. PubMed ID: 15964171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.
    Ramachandran PS; Bhattarai S; Singh P; Boudreau RL; Thompson S; Laspada AR; Drack AV; Davidson BL
    PLoS One; 2014; 9(4):e95362. PubMed ID: 24759684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7.
    Janer A; Werner A; Takahashi-Fujigasaki J; Daret A; Fujigasaki H; Takada K; Duyckaerts C; Brice A; Dejean A; Sittler A
    Hum Mol Genet; 2010 Jan; 19(1):181-95. PubMed ID: 19843541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice.
    Garden GA; Libby RT; Fu YH; Kinoshita Y; Huang J; Possin DE; Smith AC; Martinez RA; Fine GC; Grote SK; Ware CB; Einum DD; Morrison RS; Ptacek LJ; Sopher BL; La Spada AR
    J Neurosci; 2002 Jun; 22(12):4897-905. PubMed ID: 12077187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of spinal motor neurons in spinocerebellar ataxia type 1-knock-in mice.
    Takechi Y; Mieda T; Iizuka A; Toya S; Suto N; Takagishi K; Nakazato Y; Nakamura K; Hirai H
    Neurosci Lett; 2013 Feb; 535():67-72. PubMed ID: 23328439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models.
    Marinello M; Werner A; Giannone M; Tahiri K; Alves S; Tesson C; den Dunnen W; Seeler JS; Brice A; Sittler A
    Dis Model Mech; 2019 Jan; 12(1):. PubMed ID: 30559154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ataxin-7 expression analysis in controls and spinocerebellar ataxia type 7 patients.
    Einum DD; Townsend JJ; Ptácek LJ; Fu YH
    Neurogenetics; 2001 Mar; 3(2):83-90. PubMed ID: 11354830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation.
    Hearst SM; Lopez ME; Shao Q; Liu Y; Vig PJ
    J Neurochem; 2010 Aug; 114(3):706-16. PubMed ID: 20477910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.
    Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY
    Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reelin is a target of polyglutamine expanded ataxin-7 in human spinocerebellar ataxia type 7 (SCA7) astrocytes.
    McCullough SD; Xu X; Dent SY; Bekiranov S; Roeder RG; Grant PA
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21319-24. PubMed ID: 23236151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinocerebellar ataxia type 1.
    Donato SD; Mariotti C; Taroni F
    Handb Clin Neurol; 2012; 103():399-421. PubMed ID: 21827903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal administration of IGF-I improves behavior and Purkinje cell pathology in SCA1 mice.
    Vig PJ; Subramony SH; D'Souza DR; Wei J; Lopez ME
    Brain Res Bull; 2006 May; 69(5):573-9. PubMed ID: 16647585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation.
    Hübener J; Vauti F; Funke C; Wolburg H; Ye Y; Schmidt T; Wolburg-Buchholz K; Schmitt I; Gardyan A; Driessen S; Arnold HH; Nguyen HP; Riess O
    Brain; 2011 Jul; 134(Pt 7):1925-42. PubMed ID: 21653538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between ataxin-1 nuclear inclusions and Purkinje cell specific proteins in SCA-1 transgenic mice.
    Vig PJ; Subramony SH; Qin Z; McDaniel DO; Fratkin JD
    J Neurol Sci; 2000 Mar; 174(2):100-10. PubMed ID: 10727695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2.
    Niewiadomska-Cimicka A; Doussau F; Perot JB; Roux MJ; Keime C; Hache A; Piguet F; Novati A; Weber C; Yalcin B; Meziane H; Champy MF; Grandgirard E; Karam A; Messaddeq N; Eisenmann A; Brouillet E; Nguyen HHP; Flament J; Isope P; Trottier Y
    J Neurosci; 2021 Jun; 41(22):4910-4936. PubMed ID: 33888607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.